Plenaries

 

Plenary talk
Using Mobile Data and Global Mapping to Tackle the Next Outbreak: Andy Tatem (UK/Sweden)

​

Plenary talk
Collaborating with the Innate Immune System to Control Antibiotic-resistant Superbugs: Victor Nizet (US)

​

Plenary talk
At the Forefront of Hepatitis C Virus Elimination: Noor Hisham Abdullah (Malaysia) and Manal El-Sayed (Egypt)

            

Plenary Session - Malaria

• The Threat of Multidrug Resistant Plasmodium falciparum Malaria: Elizabeth Ashley (Lao PDR)

• The Key to a Better Malaria Vaccine: Faith Osier (Kenya)

• Plasmodium knowlesi-Malaria at the One Health Interface: Fong Mun Yik (Malaysia)

            

Plenary Session - Emerging Infectious Diseases Preparedness 

• Population Displacement, Conflict and War as Drivers of Emerging Diseases: TBD

• Ecosystem Destruction and Loss of Biodiversity: Peter Daszak (US)

• Epidemic Preparedness in China, the Region and Beyond: George Gao (China)

            

Plenary Session - Dengue

• Innovations in Clinical Management - Novel Therapeutics, Diagnostics and Vaccine Update: Bridget Wills (Vietnam)

• Dengue - Unusual Clinical Presentations: Sharifah Faridah Syed Omar (Malaysia)

• ABUZZ: Citizen Science for Mosquito Monitoring: Haripriya Vaidehi Narayanan (US)

​

 

Meet-the-Expert Sessions

​

A Career in Public Health and Global Health           

• Rana Hajjeh (Egypt)

• Wan Noraini Wan Mohamed Noor (Malaysia)

                        

Meet-the-Editors
(developed in collaboration with Elsevier)            

• International Journal of Infectious Diseases: Eskild Petersen (Oman)

• The Lancet Digital Health: Rupa Sarkar (UK)

• The Lancet infectious Diseases: John McConnell (UK)

• IDCases: Larry Lutwick (US)

            

Urinary Tract Infections - Updates in Prevention and Management

• Sally Roberts (New Zealand)

            

Surgical site infections - Updates in Prevention, Diagnosis and Treatment

• Alison Holmes (UK)

 

Managing Resistant Fungal Infections

• TBD

 

… AND MORE TO COME!

            

Symposia

​

Infectious disease innovations for a digital world
(developed in collaboration with the Lancet ID and the Lancet Digital Health)          

• The Use of Mobile Phone Data for Outbreak Tracking: Amy Wesolowski (US)

• Genomics and Metagenomics Approaches to the Diagnosis, Treatment and Surveillance of Infectious Diseases: Jennifer Gardy (US)

• TBD

            

Vaccines to Prevent Respiratory Disease Morbidity and Mortality
(developed in collaboration with the Bill & Melinda Gates Foundation)      

• Pneumococcal Pneumonia, RSV, Influenza, and Pertussis: Critical Updates: Keith Klugman (US)

• Introduction of and Access to PCV Vaccination in Low- and Middle-income Countries: Bill Hausdorff (US)

• Lessons Learned from the Genomic Surveillance ofStreptococcus pneumoniae: Stephanie Lo (UK)

            

HIV - Hot Topics (developed in collaboration with the International Aids Society)

• HIV Pre-Exposure Prophylaxis Updates for the Infectious Disease Physician: Iskandar Azwa (Malaysia)

• Same Day ART Initiation: Reshmie Ramautarsing (Thailand)

• Treatment of Latent TB Infection: Sean Wasserman (South Africa)

            

The Great Debates 1   

Antibiotics for Diarrheal Disease: Miguel O'Ryan (Chile) and Per Ashorn (Finland)

            

Serosurveillance for Spillover of High Consequence Zoonotic Viruses at the Human-Animal Interface 
(developed in collaboration with EcoHealth Alliance)         

• Risk of bat borne virus spillover in Northeast India: TBD

• Seasonal seroprevalence of Nipah virus infection in Pteropus lylei Bats in Thailand, 2017-2018: TBD

• Serological Biosurveillance for Spillover of Henipaviruses and Filoviruses at Agricultural and Hunting Human-Animal Interfaces in Peninsular Malaysia: TBD

            

Enterovirus Infections in Asia Pacific – Critical Updates
(ISID Member-proposed symposium competition winner)

• Asia-Pacific Network for Enterovirus Surveillance Overview and Development of Enterovirus A71 Vaccines: Min-Shi Lee (Taiwan)

• Laboratory Diagnosis and Management of Enterovirus Infections: Yoke-Fun Chan (Malaysia)

• Genetic and Antigenic Evolution of Enteroviruses in Asia Pacific: Jiratchaya Puenpa (Thailand)

            

Clinical Management of Multidrug Resistant Infections
(developed in collaboration with ESCMID)         

Symposium under development

            

Pandemic Preparedness - 25 years ProMED
(developed in collaboration with ProMED – the Program for Monitoring Emerging Diseases)     

• Climate and Global Disease Outbreaks: The View from 36,000 km: Assaf Anyamba (US)

• TBD

• ProMED – 25 years: Larry Madoff (US), Linda MacKinnon (US) and Marjorie Pollack (US)

            

Viral Hepatitis
(developed in collaboration with DNDi)                   

• Decentralized testing and treatmentDNDi

• TBD

                        

Scientific Story Telling

• Session under development

            

Global Action on AMR – New Control and Treatment Strategies
(developed in collaboration with the Japanese Association for Infectious Diseases)        

• International Comparison of Antibiotic-resistant Bacteria: Katsumi Shigemura (Japan)

• Enhancing the International Coordination of Antimicrobial Resistance Research and Development:TBD

• Adjunctives and Alternatives to Antibiotics - Phages, Microbiome-modulating, Immune Approaches and Others: Ursula Theuretzbacher (Austria)

            

Vaccine Hesitancy      

• Vaccine Hesitancy in a Post-fact World – the Role of Social Media and Other Drivers of Vaccine Hesitancy in High-income Countries: TBD 

• Vaccine Hesitancy – Drivers in Low- and Middle-income Countries: Lulu Bravo (Philippines)

• Q/A session – moderators: Anita Shet (US)

            

Rabies - Key Areas of Focus for Successful Elimination
(ISID Member-proposed Symposium Competition winner)         

• Enhanced Laboratory-based Surveillance is Essential to the Success of the '0 by 30' Global Rabies Program: Gowri Yale (India)

• Mass Canine Vaccination: A Proven One Health Context for the Elimination of Human Rabies Caused by Dogs: Umme Ruman Siddiqi (Bangladesh)

• The Futility of Therapeutics and the Utility of Intradermal Immunization for Human Rabies Prophylaxis: TBD

            

Utilizing newer diagnostic tests         

• Translation of Microbial Genomics into Public Health and Clinical Microbiology: Ben Howden (Australia)

• Utilization of POC Tests and Biomarkers in Infectious Diseases: TBD

• The Lab of the Future: TBD

            

The Great Debates II - Access to medicines

• Debaters to be determined. 

            

Tackling Drug-resistant Gonorrhoea 
(developed in collaboration with GARDP)

• Session under development

            

Neglected Tropical Diseases  

• Leptospirosis: Zamberi Sekawi (Malaysia)

• TBD

• TBD

            

Current Updates in Tuberculosis       

• MDRTB Treatment Update: Sean Wasserman (South Africa)

• TB - Molecular Epidemiology and Control in an Urban City: TBD

• TB Experimental Therapeutics - A Look into the Future: Greg Cook (New Zealand)

                        

Pediatric Infectious Diseases - Hot Topics       

• A Chance at Life – Optimizing the Management of Neonatal Sepsis in Low- and Middle-income Countries: TBD

• The Global Re-emergence of Measles and other Vaccine Preventable Diseases: TBD

• HPV - TBD

 

…AND MORE TO COME!

 

Workshops

​

Antibiotic Allergy Workshop
(in collaboration with the Australasian Society for ID)

• Defining antimicrobial allergy: Natasha Holmes 

• Recognizing the phenotype: Siew Eng Choon 

• Antibiotic allergy cross-reactivity: Jason Trubiano 

• Penicillin allergy testing: Elizabeth Phillips 

• Antibiotic allergy assessment tools: Misha Devchand 

• Practical AMS solutions for all hospital settings: Kyra Chua 

• Approaches in antimicrobial associated SCAR: Elizabeth Phillips 

• Antibiotic Allergy in Practice – Case scenarios: Jason Trubiano 

• Antibiotic Allergy in Practice – Case scenarios: Sasheela Sri La Sri Ponnampalavanar

            

Hand Hygiene Workshop

• Workshop under development      

                                                

Mastercourse in Vaccinology

Anita Shet (US), Lulu Bravo (Philippines)

• How do vaccines work? 

• Immune response to vaccines & role of adjuvants

• Combination vaccines: can we give too many antigens?

• New developments in vaccine technology for more efficient vaccines

• Q & A

• Disease and vaccine surveillance systems and public health value of vaccines (60 mins)

• How to measure the impact of vaccines

• Importance of disease surveillance in developing impactful vaccines

• Vaccine safety monitoring

• Q & A

• Vaccine economics

• Interpretation of the health economic analyses of vaccines (cost-effectiveness, cost-savings, return on investment); broader socio-economic benefits of vaccines

• Q & A

• Vaccination of specific groups 

• Vaccination of pregnant women

• Vaccination of older adults

• Q & A

• Clinical cases discussion

• Quiz with clinical case discussions

                        

Guide to Infection Control Workshop

• Workshop under development

 

… AND MORE TO COME!